We obtain coagulation labs on nearly every critically ill patient. However, our understanding of these labs remains relatively superficial. Meanwhile, the addition of thromboelastography (TEG) has rendered matters even more complex, by providing an alternative strategy for monitoring coagulation. This chapter attempts to sift through a rational approach to coagulation labs, but much work remains to fully elucidate this topic.
The IBCC chapter is located 👉 here.
- The podcast & comments are below.
Follow us on iTunes
- IBCC – Cardiac glycoside poisoning (including digoxin) - May 13, 2021
- IBCC – Approach to the poisoned patient - May 10, 2021
- IBCC – Thrombotic microangiopathies (TTP, HUS, et al.) - May 6, 2021